The invention discloses preparation and application of a ternary carrier-free injectable hydrogel formed by co-assembling glycyrrhizic acid,
norcantharidin and
metal copper ions. The hydrogel can form gel under the condition of not adding auxiliary materials, has excellent gel material properties such as injectability,
heat sensitivity and stability, and can be used as an ideal anti-tumor
drug to be clinically applied. The hydrogel has the effects of inducing
tumor cell apoptosis and
copper death and resisting
inflammation, and cooperatively regulates and controls a
tumor microenvironment; and
laser irradiation is combined to assist in enhancing the Fenton-like effect, so that chemical kinetic treatment of tumors is realized. In a
Hepa1-6 tumor-bearing
liver cancer mouse model, the hydrogel has an excellent anti-tumor effect, and the
drug effect is obviously superior to that of each
monomer drug group. In addition, the hydrogel has good
biocompatibility, and is a novel anti-tumor hydrogel which is simple to prepare, green and has clinical transformation potential.